Carna Biosciences, Inc. (4572.T)
JPY 282.0
(0.0%)
JPY 282.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 182.97 Million JPY | -39.09% |
| 2022 | 300.39 Million JPY | -44.36% |
| 2021 | 539.88 Million JPY | 25.62% |
| 2020 | 429.78 Million JPY | -41.02% |
| 2019 | 728.75 Million JPY | 6.14% |
| 2018 | 686.56 Million JPY | 10.01% |
| 2017 | 624.11 Million JPY | -10.55% |
| 2016 | 697.71 Million JPY | 226.62% |
| 2015 | 213.61 Million JPY | 32.78% |
| 2014 | 160.87 Million JPY | 14.47% |
| 2013 | 140.53 Million JPY | 4.77% |
| 2012 | 134.14 Million JPY | -34.04% |
| 2011 | 203.35 Million JPY | 8.83% |
| 2010 | 186.86 Million JPY | 139.56% |
| 2009 | 78 Million JPY | 0.0% |
| 2008 | - JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 88.4 Million JPY | -25.33% |
| 2024 Q1 | 118.4 Million JPY | -35.29% |
| 2023 Q4 | 182.97 Million JPY | 2.56% |
| 2023 Q2 | 226.39 Million JPY | -11.7% |
| 2023 FY | 182.97 Million JPY | -39.09% |
| 2023 Q3 | 178.39 Million JPY | -21.2% |
| 2023 Q1 | 256.39 Million JPY | -14.65% |
| 2022 Q3 | 331.85 Million JPY | -18.24% |
| 2022 Q2 | 405.87 Million JPY | -12.88% |
| 2022 Q1 | 465.88 Million JPY | -13.71% |
| 2022 FY | 300.39 Million JPY | -44.36% |
| 2022 Q4 | 300.39 Million JPY | -9.48% |
| 2021 Q3 | 274.89 Million JPY | -16.07% |
| 2021 Q2 | 327.51 Million JPY | -10.54% |
| 2021 Q1 | 366.08 Million JPY | -14.82% |
| 2021 Q4 | 539.88 Million JPY | 96.4% |
| 2021 FY | 539.88 Million JPY | 25.62% |
| 2020 Q2 | 579.27 Million JPY | -10.47% |
| 2020 Q1 | 647.01 Million JPY | -11.22% |
| 2020 FY | 429.78 Million JPY | -41.02% |
| 2020 Q4 | 429.78 Million JPY | -13.62% |
| 2020 Q3 | 497.52 Million JPY | -14.11% |
| 2019 FY | 728.75 Million JPY | 6.14% |
| 2019 Q1 | 611.15 Million JPY | -10.98% |
| 2019 Q2 | 555.32 Million JPY | -9.14% |
| 2019 Q3 | 796.49 Million JPY | 43.43% |
| 2019 Q4 | 728.75 Million JPY | -8.51% |
| 2018 Q3 | 747.97 Million JPY | -10.07% |
| 2018 Q4 | 686.56 Million JPY | -8.21% |
| 2018 Q2 | 831.74 Million JPY | -7.74% |
| 2018 FY | 686.56 Million JPY | 10.01% |
| 2018 Q1 | 901.48 Million JPY | 44.44% |
| 2017 Q3 | 563.02 Million JPY | -8.09% |
| 2017 FY | 624.11 Million JPY | -10.55% |
| 2017 Q4 | 624.11 Million JPY | 10.85% |
| 2017 Q2 | 612.58 Million JPY | -5.49% |
| 2017 Q1 | 648.15 Million JPY | -7.1% |
| 2016 Q1 | 195.55 Million JPY | -8.46% |
| 2016 FY | 697.71 Million JPY | 226.62% |
| 2016 Q4 | 697.71 Million JPY | -4.85% |
| 2016 Q3 | 733.28 Million JPY | 28.59% |
| 2016 Q2 | 570.26 Million JPY | 191.62% |
| 2015 Q2 | 141.41 Million JPY | -6.44% |
| 2015 Q1 | 151.14 Million JPY | -6.05% |
| 2015 FY | 213.61 Million JPY | 32.78% |
| 2015 Q4 | 213.61 Million JPY | -7.8% |
| 2015 Q3 | 231.68 Million JPY | 63.83% |
| 2014 FY | 160.87 Million JPY | 14.47% |
| 2014 Q4 | 160.87 Million JPY | -10.93% |
| 2014 Q3 | 180.6 Million JPY | 47.44% |
| 2014 Q2 | 122.49 Million JPY | -6.86% |
| 2014 Q1 | 131.51 Million JPY | -6.42% |
| 2013 FY | 140.53 Million JPY | 4.77% |
| 2013 Q1 | 115.83 Million JPY | -13.65% |
| 2013 Q2 | 107.18 Million JPY | -7.47% |
| 2013 Q3 | 149.55 Million JPY | 39.53% |
| 2013 Q4 | 140.53 Million JPY | -6.03% |
| 2012 FY | 134.14 Million JPY | -34.04% |
| 2012 Q2 | 168.74 Million JPY | -9.3% |
| 2012 Q3 | 151.44 Million JPY | -10.25% |
| 2012 Q4 | 134.14 Million JPY | -11.43% |
| 2012 Q1 | 186.05 Million JPY | -8.51% |
| 2011 FY | 203.35 Million JPY | 8.83% |
| 2011 Q4 | 203.35 Million JPY | -7.84% |
| 2011 Q1 | 172.41 Million JPY | -7.73% |
| 2011 Q3 | 220.66 Million JPY | 39.69% |
| 2011 Q2 | 157.96 Million JPY | -8.38% |
| 2010 Q1 | 176 Million JPY | 125.64% |
| 2010 Q2 | 165.75 Million JPY | -5.82% |
| 2010 Q4 | 186.86 Million JPY | -7.18% |
| 2010 FY | 186.86 Million JPY | 139.56% |
| 2010 Q3 | 201.3 Million JPY | 21.45% |
| 2009 Q4 | 78 Million JPY | -2.5% |
| 2009 Q3 | 80 Million JPY | 0.0% |
| 2009 Q2 | - JPY | 0.0% |
| 2009 Q1 | - JPY | 0.0% |
| 2009 FY | 78 Million JPY | 0.0% |
| 2008 FY | - JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | 92.591% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 95.054% |
| Linical Co., Ltd. | 3 Billion JPY | 93.905% |
| Trans Genic Inc. | 2.25 Billion JPY | 91.893% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -7831.123% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | 92.598% |
| AnGes, Inc. | 362.67 Million JPY | 49.55% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -71.243% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 99.753% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | 22.464% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 83.5% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | 79.328% |
| RaQualia Pharma Inc. | 367.71 Million JPY | 50.241% |
| Chiome Bioscience Inc. | 291 Million JPY | 37.123% |
| Kidswell Bio Corporation | 2.57 Billion JPY | 92.894% |
| PeptiDream Inc. | 22.79 Billion JPY | 99.197% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | 41.945% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | 72.486% |
| Healios K.K. | 4.53 Billion JPY | 95.963% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -62.641% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -28.083% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -87.582% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | 80.395% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | 81.098% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | 74.725% |
| StemCell Institute Inc. | 8.78 Million JPY | -1983.003% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | -20.973% |